Health care management

New Study: Creating Two-Part Drug Pricing System Would Ensure Prices More Accurately Reflect How Patients Value Drugs

Retrieved on: 
Tuesday, August 3, 2021

Value assessment frameworks, such as the one used by the Institute for Clinical and Economic Review, or ICER, assume that a centralized agency is necessary to determine a medicine's value.

Key Points: 
  • Value assessment frameworks, such as the one used by the Institute for Clinical and Economic Review, or ICER, assume that a centralized agency is necessary to determine a medicine's value.
  • "An efficient market process is the only way to ensure that drug prices accurately reflect value.
  • By creating a two-part drug pricing system, we can better reflect a drug's value for patients and insurers, ensure affordability, and provide incentives for future innovation," concluded Winegarden.
  • Insurers would pay the access fee on behalf of patients, ensuring that everyone covered by the insurance can access the drug.

Quipt Home Medical to Participate at the 41st Annual Canaccord Growth Conference on August 10th - 12th

Retrieved on: 
Wednesday, July 28, 2021

The live webcast of the presentation will be available by visiting the investors' section of the company's website at www.quipthomemedical.com .

Key Points: 
  • The live webcast of the presentation will be available by visiting the investors' section of the company's website at www.quipthomemedical.com .
  • The webcast will also be available for replay on the company's website following the event.
  • The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market.
  • The Companys organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patients services and making life easier for the patient.

Broadstreet HEOR And Sprout Health Solutions Publish New Research That Reinforces Complex Treatment Burden For Hemophilia A

Retrieved on: 
Tuesday, July 20, 2021

The research shows a preference for a subcutaneous therapy compared to intravenous treatment, and that preference was also evident in qualitative research with patients and caregivers.

Key Points: 
  • The research shows a preference for a subcutaneous therapy compared to intravenous treatment, and that preference was also evident in qualitative research with patients and caregivers.
  • Broadstreet HEOR partnered with Sprout Health Solutions to conduct in-depth interviews of adults with hemophilia and caregivers of children/adolescents with hemophilia.
  • Broadstreet Health Economics & Outcomes Research (HEOR) creates custom, evidence-based solutions for value and access questions across a drug product life cycle, delivered with novel, elegant data visualizations.
  • Their two divisions, Sprout Health Outcomes and Sprout Behaviour Change, work synergistically to provide effective solutions for pharma, biotech and digital health partners.

Sweetch Secures $20 Million Series A to Accelerate Fully Automated Hyper-personalized Engagement Between Health Ecosystem Players and People with Chronic Conditions

Retrieved on: 
Monday, July 19, 2021

90 percent of healthcare costs in the US are attributable to chronic diseases, which afflict 50 percent of the population.

Key Points: 
  • 90 percent of healthcare costs in the US are attributable to chronic diseases, which afflict 50 percent of the population.
  • This seemingly contradictory statement can be achieved through technology like Sweetch," said Dr. Doron Dinstein, Venture Partner at Entre Capital.
  • Sweetch provides a hyper-personalized, scalable and cost-effective solution to increase patient adherence across various aspects of disease management and improve clinical outcomes for people with chronic conditions.
  • Sweetch is the developer of hyper-personalized engagement solutions for chronic conditions.

Hines & Associates, Inc. Acquired by Global Excel Management Inc.

Retrieved on: 
Thursday, July 1, 2021

Hines & Associates, Inc. (Hines) is pleased to announce it has been acquired by Global Excel Management Inc. (Global Excel) effective July 1, 2021.

Key Points: 
  • Hines & Associates, Inc. (Hines) is pleased to announce it has been acquired by Global Excel Management Inc. (Global Excel) effective July 1, 2021.
  • We look forward to joining Global Excel and leveraging our combined resources and expertise to enhance our service offering, said Judy Hines, President of Hines.
  • Hines has built a very strong reputation providing case, utilization and disease management services focused on the U.S. market, said Reg Allatt, CEO of Global Excel.
  • Hines ( www.hinesassoc.com ) was founded in 1987 and is a leading US-based provider of healthcare management services including: precertification, utilization management, advocacy, care coordination, case management, specialty case management, chronic condition management (disease management), behavioral health, wellness and total population management programs.

VigiLanz Launches Intelligent Audit Solution for Hospitals, Streamlining and Automating Processes and Expanding #1 Rated Clinical Surveillance Platform

Retrieved on: 
Tuesday, June 29, 2021

MINNEAPOLIS, June 29, 2021 /PRNewswire/ -- VigiLanz , a clinical surveillance company, today announced the launch of a new audit solution built on VigiLanz's award-winning enterprise software platform.

Key Points: 
  • MINNEAPOLIS, June 29, 2021 /PRNewswire/ -- VigiLanz , a clinical surveillance company, today announced the launch of a new audit solution built on VigiLanz's award-winning enterprise software platform.
  • The new solution, VigiLanz Audit , complements VigiLanz's existing safety , quality , and risk products by streamlining, automating, and optimizing audit processes.
  • In addition to saving time and resources, VigiLanz Audit helps hospitals quickly identify emerging risks and ensure continuous quality improvements.
  • VigiLanz Audit supports every type of quality assurance (QA) and quality improvement (QI) healthcare audit, including clinical, environmental, billing compliance, and accreditation readiness.

Hospital IQ Raises $25 Million to Meet Market Demand for its Software which Optimizes Health System Operations

Retrieved on: 
Monday, June 28, 2021

Were excited to scale our operations alongside industry demand and enable more health systems to optimize their performance while providing high-quality care as we advance healthcares digital age.

Key Points: 
  • Were excited to scale our operations alongside industry demand and enable more health systems to optimize their performance while providing high-quality care as we advance healthcares digital age.
  • Hospital IQs software addresses a hospitals highest costs staffing and patient throughput, allowing hospitals to operate more efficiently.
  • Hospital IQ has a very experienced and talented team leading the company, and we look forward to partnering with them to meet the markets demand for its solutions.
  • Hundreds of leading hospitals and health systems rely on Hospital IQ to help them make the right operational decisions the first time, every time.

Quipt Home Medical to Begin Trading on Nasdaq

Retrieved on: 
Thursday, May 27, 2021

The live audio webcast can be found on the investor section of the Companys website through the following link: www.quipthomemedical.com

Key Points: 
  • The live audio webcast can be found on the investor section of the Companys website through the following link: www.quipthomemedical.com
    ABOUT QUIPT HOME MEDICAL CORP.
  • The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market.
  • The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management.
  • Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian and United States securities legislation.

Longitudinal Study Finds One Medical’s Member-Based & Technology-Powered Primary Care Model Delivers Outsized Impact in Controlling Diabetes

Retrieved on: 
Monday, May 24, 2021

The CDC estimates that as of 2020, approximately 34 million Americans, just over 10% of the population, had diabetes.

Key Points: 
  • The CDC estimates that as of 2020, approximately 34 million Americans, just over 10% of the population, had diabetes.
  • Through its human-centered and technology-powered model, One Medical seeks to address this public health concern by leveraging its multi-modal care strategy.
  • Using One Medicals longitudinal primary care model, these patients saw their average HbA1c levels decrease by 19%, from 10.7% to 8.7%.
  • While some may think they need specialty services to properly manage their chronic health issues, chronic care management is actually a core component of One Medicals modernized primary care model.

Aveanna Elects Former Deputy Surgeon General Erica Schwartz, MD, JD, MPH to Board of Directors

Retrieved on: 
Wednesday, May 19, 2021

b'ATLANTA, May 19, 2021 /PRNewswire/ -- Aveanna Healthcare Holdings Inc. ("Aveanna") announced today that Erica Schwartz, MD, JD, MPH was elected to its Board of Directors on May 13, 2021 for a three-year term.

Key Points: 
  • b'ATLANTA, May 19, 2021 /PRNewswire/ -- Aveanna Healthcare Holdings Inc. ("Aveanna") announced today that Erica Schwartz, MD, JD, MPH was elected to its Board of Directors on May 13, 2021 for a three-year term.
  • She will also serve on the Clinical Quality and Compliance Committee of the Board.
  • "Erica is an outstanding leader with over 20 years of experience managing large and diverse healthcare systems.
  • Aveanna directly addresses the most pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home, the lower cost care setting preferred by patients.\n'